Verified email at gmail.com
Nabi Nazari, Akram Aligholipour, and Masoud Sadeghi
BMC Women's Health, eISSN: 14726874, Published: 1 December 2020 Springer Science and Business Media LLC
Abstract Background Multiple sclerosis (MS) is a chronic, unpredictable, neurodegenerative disease, significantly associated with psychological, behavioral, cognitive, and emotional consequences. MS is more common in females than males and frequently affects women during their reproductive years. Despite the frequent mental disorders, comorbidities, and emotional problems in People with MS (PwMS), these conditions are too often underdiagnosed and undertreated. Objective This study aimed to examine the efficacy of a group format of the Unified Protocol (UP) for the Transdiagnostic treatment of depression and anxiety disorders in females with MS. Methods In the present study, Sixty-four adult females diagnosed with MS were randomized to either the UP (n = 32) or treatment-as-usual conditions. The assessment protocol included semi-structured clinical interviews and self-reports evaluating diagnostic criteria, depression, anxiety and worry symptoms, emotional regulation, and affectivity. Results Repeated measure analysis of variance (ANOVA) revealed that the UP significantly improved depression scores [Cohen’s d = − 2.11, 95% CI (− 2.72, − 1.50)], anxiety scores [Cohen’s d = − 3.34, 95% CI (− 4.01, − 2.58)], positive and negative affect scale (PANAS)-positive affect scores [Cohen’s d = 1.46, 95% CI (1.46, 2.01)], PANAS-negative affect scores [Coen’s d = − 2.21, 95% CI (− 2.84, − 1.60)], difficulties emotion regulation scale scores [Cohen’s d = 1.40, 95% CI (− 0.87, − 0.03)], and Worry scale scores [Cohen’s d = − 0.45, 95% CI (− 0.95, − 0.04)] at the end of treatment relative to compared to the control condition. Also, treatment gains were maintained at the three-month follow-up (p < 0.001). Conclusion The findings provide the support that the UP could be an additional efficient psychological treatment for females with MS. ISRCTN Number: ISRCTN95459505.
Nabi Nazari, Masood Sadeghi, Ezatolah Ghadampour, and Davod Mirzaeefar
BMC Psychology, eISSN: 20507283, Published: 1 December 2020 Springer Science and Business Media LLC
Abstract Background Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. MS is significantly associated with a high rate of psychological, behavioral, and emotional consequences. Despite the frequent mental disorders, high rate of psychological comorbidities, and emotional problems in people with MS (PwMS), these conditions are often underdiagnosed and undertreated. This study aimed to examine the efficacy of a group format of the unified protocol for the transdiagnostic treatment of emotional disorders in adult PwMS associated with an emotional disorder. Methods Seventy adult PwMS were randomized using an internet-based computer system to either the unified protocol (n = 35) or treatment as usual condition. The assessment protocol included semi-structured clinical interviews and self-reports evaluating diagnostic criteria, depression, anxiety and worry symptoms, emotional dysregulation, and affectivity. Results The parametric test of analysis of covariance, followed the intent to treat analyses, revealed the unified protocol significantly changed depression symptoms (Cohen’s d = 1.9), anxiety symptoms (Cohen’s d = 2.16), worry symptoms (Cohen’s d = 1.27), emotion dysregulation (Cohen’s d = 0.44), positive affect (Cohen’s d = 1.51), and negative affect (Cohen’s d = 1.89) compared with the control group. The unified protocol also significantly improved outcome scores at the end of treatment relative to baseline (p < .001). Conclusion The findings support that the unified protocol could be an additional efficient psychological treatment for PwMS. Trial registration IRCT, number: IRCT20190711044173N1. Registered 31october 2019, https://en.irct.ir/user/trial/40779/view.
Journal of Advanced Pharmacy Education and Research, eISSN: 22493379, Pages: 49-54, Published: 2020
Mark D. Griffiths and Nabi Nazari
International Journal of Mental Health and Addiction, ISSN: 15571874, eISSN: 15571882, Published: 2020 Springer Science and Business Media LLC
The Problem Gambling Severity Index (PGSI) has been the most frequently used instrument for prevalence studies for problem gambling in recent years. To date, there have been very few gambling studies among Persian populations. The objective of the present study was to investigate the reliability and validity of the Persian version of the PGSI. The original version of the PGSI was translated and back-translated into Persian, followed by a pilot study. A sample of Iranian online gamblers (n = 858) was recruited utilizing social media platforms. Results showed that the Persian PGSI had excellent internal consistency (Cronbach’s alpha coefficient = 0.90; composite reliability = 0.91) and moderate test-retest reliability after 4–6 weeks using intraclass coefficient (0.41 with 95% CI [.34, .49]). The maximum likelihood confirmatory factor analysis for one-factor PGSI model fitted well (χ2/df = 2.81, CFI = .974, SRMR = .028, PCLOSE > .05, RMSEA = .057, 90% CI [.037, .077]). As for criterion-related validity, the Persian PGSI score correlated with the score on the Hospital Anxiety Depression Scale, which assesses depression (r = .54, p < .01) and anxiety (r = .40, p < .01). The Persian PGSI is a reliable and valid instrument for assessing the prevalence of problem gambling among Persian populations.
Nabi Nazari, , and Davod Mirzaei Far
Journal of Intellectual Disability - Diagnosis and Treatment, eISSN: 22922598, Pages: 119-133, Published: 2019 Lifescience Global
Lila Rajabion, Nabi Nazari, Mohammadreza Bandarchi, Aliakbar Farashiani, and Shervin Haddad
Human Systems Management, ISSN: 01672533, Pages: 365-384, Published: 2019 IOS Press